Figure 1. Measurement of GFP-HHV-8 Infectivity

HFF cells treated with DMEM (A, B, D and E) or with DMEM containing 1.5 mM of GRGDTP peptide (C and F) for 1 hr at 4ЊC were either mock infected (A and D) or infected with GFP-HHV-8 (B, C, E, and F) at 37ЊC for 2 hr, washed, and incubated at 37ЊC for 3 days with growth medium. Green fluorescent cells indicative of GFP-HHV-8 entry and infection were counted (A, B, and C). Approximately
( Figure 2A ). Even though the inhibition observed with gions probably have contributed to the higher percentage of inhibition by the anti-gB antibodies. Nevertheless, 15 mM of RGDgBN-1 peptide was significantly higher than the GRGESP control peptide, it was lower than the inhibition by anti-RGDgB-N1 antibodies suggests a role for HHV-8 gB RGD motif in the interaction with the target inhibition observed with the GRGDTP and RGD peptides. This could be due to aggregation of the 18-aacells, potentially with integrins. long RGDgBN-1 peptide at higher concentrations more than the shorter RGD and GRGDTP peptides. GFP- Figures 1D-1F) , inhibition comparable to act with integrins by RGD-dependent and -independent mechanisms, inhibited HHV-8 infectivity by 50% Ϯ 3% GFP expression inhibition was observed with the RGDcontaining peptides (data not shown). Inhibition by the at 50 g/ml concentrations ( Figure 2C ), and inhibition did not increase significantly at 80 g/ml concentrations RGD peptides suggests a potential RGD-dependent HHV-8 interaction with the host cell surface and, hence, (data not shown). When cells were incubated with 25 and 50 g/ml of laminin, also known to bind integrins a role for integrins in the biology of HHV-8.
Inhibition of HHV-8 Infection by Integrin Ligands To determine the role of integrins in HHV-8 infection, HHV-8 used here is not clonal and contains both wildtype and recombinant viruses. Nevertheless, when vi-HFF cells were incubated with ECM proteins before GFP-HHV-8 infection. Fibronectin (FN), known to interrus-infected cells were monitored for the ORF 73 protein expression (
by RGD-dependent and -independent mechanisms, a moderate but significant (p Ͻ 0.05; chi-square test) inAntibodies to Peptides Containing RGD Amino Acids Inhibit HHV-8 Infection crease in GFP-HHV-8 infectivity was observed ( Figure  2C ). The reason for this increased infection is under Rabbit antibodies directed against the RGD-containing peptide (RGDgB-N1) significantly inhibited the GFPfurther investigation. In contrast, collagen type I, tenascin, vitronectin, BSA, and chondroitin sulfate A and C HHV-8 infection (p Ͻ 0.05; chi-square test) in a dosedependent manner ( Figure 2B ). In contrast, rabbit antihad no significant effect on GFP-HHV-8 infectivity (Figure 2C) . These results also suggested a possible role of bodies against peptides lacking the RGD motif (gB-N2-GVENTFTDRDDVNTTVFLQPVEGLT and gB-C-RGYKP integrins in HHV-8 infectivity. LTQSLDISPETGE) did not show any significant inhibition ( Figure 2B ). The 50% inhibition by anti-RGDgB-N1 antiAntibodies to ␣3 and ␤1 Integrins Inhibit HHV-8 Infectivity bodies at 30 g/ml concentration was comparable to the inhibition by rabbit anti-gB IgG antibodies ( Figure  FN binds to ␣3␤1, ␣5␤1, ␣8␤1, ␣V␤1, ␣V␤3, ␣V␤5, ␣V␤6, and ␣II␤3 integrins via the RGD sequence and to ␣2␤1, 2B), and antibodies against additional immunogenic re-␣4␤1, ␣4␤7, and ␣V␤8 integrins in an RGD-independent manner (Plow et al., 2000) . Monoclonal antibodies against the RGD binding ␣3 and ␤1 integrin subunits inhibited HHV-8 infectivity by 48% Ϯ 4% and 35% Ϯ 5%, respectively, in HFF cells ( Figure 3A ) and by 46% Ϯ 2% and 36% Ϯ 3%, respectively, in HMVEC-d cells ( Figure 3A) . The difference between the percentage inhibition of HHV-8 infectivity by MAbs to ␣3 and ␤1 integrin subunits was statistically significant (p Ͻ 0.05). About 30% Ϯ 5% of GFP-HHV-8 infectivity was also inhibited by MAb against the RGD-independent ␣2␤1 integrin, in HFF and HMVEC-d cells ( Figure 3A) . However, there was no significant difference between the inhibition by ␤1 and ␣2␤1 MAbs, and the similarities in the inhibition levels suggest that inhibition with anti-␣2␤1 MAbs could be due to crossreactivity with the ␤1 integrin subunit. Similar isotype-specific antibodies against other RGD and non-RGD binding (␣1, ␣6, ␣V, ␤4, ␣5␤1, ␣V␤3, ␣V␤5, and ␣V␤6) integrins did not show any significant inhibition of HHV-8 infectivity ( Figure 3A) , thus demonstrating the specificity of inhibition by anti-␣3 and anti-␤1 antibodies.
MAbs to ␣3 and ␤1 integrins inhibited HHV-8 infectivity in a dose-dependent manner with an optimal antibody concentration of about 2 g/ml ( Figure 3B ). When antibodies against ␣3 and ␤1 subunits or antibodies against ␣2␤1, ␣3, and ␤1 integrins were mixed and added to the HFF cells prior to infection, there was no significant additive effect of inhibition ( Figure 3B ). Incomplete inhibition of HHV-8 infectivity by the anti-␣3 and anti-␤1 antibodies could be attributed to the nature of antibodies and/or due to additional cell surface molecules recognized by HHV-8. Nevertheless, these results implicate an involvement of ␣3␤1 integrin in the infectious process of HHV-8.
Soluble ␣3␤1 Integrin Blocks HHV-8 Infection
The ␣3 integrin subunit is expressed on the cell surface only in combination with the ␤1 integrin subunit (Plow et al., 2000) . Since ␣3␤1 integrin binds FN via the RGD sequence and since antibodies against ␣3 integrin subunit neutralized infectivity better than other integrin antibodies, we focused on the role of RGD-dependent ␣3␤1 integrin in HHV-8 infectivity. Among the RGD binding integrins, only the soluble ␣3␤1 and ␣5␤1 integrins were commercially available in 10 mM octyl-b-D-glucopyranoside formulation. This formulation did not disrupt the cell membranes and was not toxic at less than 20 g/ ml of soluble integrin. Soluble ␣3␤1 blocked infection significantly in a dose-dependent manner with about 75% Ϯ 3% inhibition at 5 g/ml concentration ( Figure  3C ). The specificity of this reaction was demonstrated 1A (lanes 12-14) . Samples were resolved in SDS-7.5% PAGE and were Western blotted. Membrane strips were probed with rabbit polyclonal antibodies to ␣1 (lanes 2,  6, 9, and 12), ␣3 (lanes 3, 7, 10, and 13), or ␤1 (lanes 4, 5, 8, 11, and 14) 
